Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in lipid nanoparticles, as a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results